Ikonisys announces the completion of a private placement to accelerate its commercial development
Private placement of €0.5 million with a select circle of Italian investors and Cambria Equity Partners
Paris, June 15, 2023 – 08:00 CEST – Ikonisys SA (ISIN Code: FR00140048X2 / Mnemonic: ALIKO), a company specializing in the early and precise detection of cancer thanks to a unique and fully automated solution for medical diagnostic laboratories (the ” Issuer”), announces that it has raised €0.5 million through a private placement with Italian investors and its shareholder Cambria Equity Partners, in order to expand its international shareholder base and consolidate its financial resources, and realizing well-advanced business opportunities with prospects in the United States and Europe.